Evidence map›Paper›PMID 25579606›Full record

ArticleExperimental eye research2015

Tear metabolite changes in keratoconus.

D Karamichos, J D Zieske, H Sejersen, A Sarker-Nag, John M Asara, J Hjortdal

Open access · greenAbstract read
In one paragraph

Article in Experimental eye research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
6.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 78 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. Article
  10. Systemic and Ocular Associations of Keratoconus.Expert review of ophthalmology · 2024
    Article
  11. Review
  12. Corneal stromal regeneration-keratoconus cell therapy: a review.Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie · 2023
    Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

D KaramichosOphthalmology, University of Oklahoma - Dean McGee Eye Institute, Oklahoma City, OK, USA. Electronic address: dimitrios-karamichos@ouhsc.edu.
J D ZieskeSchepens Eye Research Institute/Massachusetts Eye and Ear and the Department of Ophthalmology Harvard Medical School, 20 Staniiford Street, Boston, MA, USA. Electronic address: james_zieske@meei.harvard.edu.
H SejersenDepartment of Ophthalmology, Aarhus University Hospital, Aarhus C, Denmark. Electronic address: henrseje@rm.dk.
A Sarker-NagOphthalmology, University of Oklahoma - Dean McGee Eye Institute, Oklahoma City, OK, USA. Electronic address: Akhee-SarkerNag@ouhsc.edu.
John M AsaraDivision of Signal Transduction/Mass Spectrometry Core, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. Electronic address: jasara@bidmc.harvard.edu.
J HjortdalDepartment of Ophthalmology, Aarhus University Hospital, Aarhus C, Denmark. Electronic address: jesper.hjortdal@dadlnet.dk.
Aarhus University · DKHarvard University Press · USDean McGee Eye Institute · USUniversity of Oklahoma · US

Funding

VectorP30CA006516 · NCI · DANA-FARBER CANCER INSTITUTE · PI A. Heather Eliassen · 1985 to 2026
$330.6M
Tuberous Sclerosis-Pathway and PathogenesisP01CA120964 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI David J. Kwiatkowski · 2007 to 2026
$35.9M
P30-CENTER CORE GRANT FOR VISION RESEARCHP30EY021725 · NEI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI Michelle C Callegan · 2011 to 2026
$10.5M
Documentation of Novel Keratoconus Markers: In Vitro and In VivoR01EY023568 · NEI · UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR · PI KARAMICHOS, DIMITRIOS · 2013 to 2015
$1.1M
NCI NIH HHS 2P01CA120964NCI NIH HHS 5P30CA006516NCI NIH HHS P01 CA120964NCI NIH HHS P30 CA006516NEI NIH HHS 5R01EY023568NEI NIH HHS P30 EY021725NEI NIH HHS R01 EY023568
6 · The paper itself

Abstract

While efforts have been made over the years, the exact cause of keratoconus (KC) remains unknown. The aim of this study was to identify alterations in endogenous metabolites in the tears of KC patients compared with age-matched healthy subjects. Three groups were tested: 1) Age-matched controls with no eye disease (N = 15), 2) KC - patients wearing Rigid Gas permeable lenses (N = 16), and 3) KC - No Correction (N = 14). All samples were processed for metabolomics analysis using LC-MS/MS. We identified a total of 296 different metabolites of which >40 were significantly regulated between groups. Glycolysis and gluconeogenesis had significant changes, such as 3-phosphoglycerate and 1,3 diphosphateglycerate. As a result the citric acid cycle (TCA) was also affected with notable changes in Isocitrate, aconitate, malate, and acetylphosphate, up regulated in Group 2 and/or 3. Urea cycle was also affected, especially in Group 3 where ornithine and aspartate were up-regulated by at least 3 fold. The oxidation state was also severely affected. Groups 2 and 3 were under severe oxidative stress causing multiple metabolites to be regulated when compared to Group 1. Group 2 and 3, both showed significant down regulation in GSH-to-GSSG ratio when compared to Group 1. Another indicator of oxidative stress, the ratio of lactate - pyruvate was also affected with Groups 2 and 3 showing at least a 2-fold up regulation. Overall, our data indicate that levels of metabolites related to urea cycle, TCA cycle and oxidative stress are highly altered in KC patients.

Indexed as

AdultAnalysis of VarianceCase-Control StudiesEye ProteinsFemaleHumansKeratoconusMaleMiddle AgedOxidative StressTandem Mass SpectrometryTearsYoung AdultEye ProteinsKeratoconusMetabolomicsOxidative stressPentacamRigid Gas Permeable lenses

Identifiers

PMID25579606
PMCPMC4436698
OpenAlexW2067425779

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.